Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.

Hocquet D, Petitjean M, Rohmer L, Valot B, Kulasekara HD, Bedel E, Bertrand X, Plésiat P, Köhler T, Pantel A, Jacobs M, Hoffman LR, Miller SI.

Environ Microbiol. 2016 Apr 27. doi: 10.1111/1462-2920.13336. [Epub ahead of print]

PMID:
27119970
2.

Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.

Richardot C, Juarez P, Jeannot K, Patry I, Plésiat P, Llanes C.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2302-10. doi: 10.1128/AAC.02622-15. Print 2016 Apr.

PMID:
26833155
3.

Increase of efflux-mediated resistance in Pseudomonas aeruginosa during antibiotic treatment in patients suffering from nosocomial pneumonia.

Riou M, Avrain L, Carbonnelle S, El Garch F, Pirnay JP, De Vos D, Plésiat P, Tulkens PM, Van Bambeke F.

Int J Antimicrob Agents. 2016 Jan;47(1):77-83. doi: 10.1016/j.ijantimicag.2015.11.004. Epub 2015 Nov 26.

PMID:
26691019
4.

Prospective evaluation of an algorithm for the phenotypic screening of carbapenemase-producing Enterobacteriaceae.

Dortet L, Cuzon G, Plésiat P, Naas T.

J Antimicrob Chemother. 2016 Jan;71(1):135-40. doi: 10.1093/jac/dkv308. Epub 2015 Oct 12.

PMID:
26462984
5.

Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.

Berrazeg M, Jeannot K, Ntsogo Enguéné VY, Broutin I, Loeffert S, Fournier D, Plésiat P.

Antimicrob Agents Chemother. 2015 Oct;59(10):6248-55. doi: 10.1128/AAC.00825-15. Epub 2015 Jul 27.

6.

The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Li XZ, Plésiat P, Nikaido H.

Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14. Review.

7.

Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD.

Richardot C, Plésiat P, Fournier D, Monlezun L, Broutin I, Llanes C.

Int J Antimicrob Agents. 2015 May;45(5):529-32. doi: 10.1016/j.ijantimicag.2014.12.029. Epub 2015 Feb 12.

PMID:
25735764
8.

Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida.

Mazurier S, Merieau A, Bergeau D, Decoin V, Sperandio D, Crépin A, Barbey C, Jeannot K, Vicré-Gibouin M, Plésiat P, Lemanceau P, Latour X.

Appl Environ Microbiol. 2015 Apr;81(7):2579-90. doi: 10.1128/AEM.04160-14. Epub 2015 Jan 30.

9.

Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients.

Chalhoub H, Tunney M, Elborn JS, Vergison A, Denis O, Plésiat P, Kahl BC, Van Bambeke F, Tulkens PM.

J Antimicrob Chemother. 2015 May;70(5):1596-8. doi: 10.1093/jac/dku551. Epub 2015 Jan 14. No abstract available.

10.

Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment.

Lucchetti-Miganeh C, Redelberger D, Chambonnier G, Rechenmann F, Elsen S, Bordi C, Jeannot K, Attrée I, Plésiat P, de Bentzmann S.

Pathogens. 2014 Apr 10;3(2):309-40. doi: 10.3390/pathogens3020309.

11.

Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.

Segonds C, Thouverez M, Barthe A, Bossuet-Greif N, Tisseyre L, Plésiat P, Vergnaud G, Chabanon G, Pourcel C.

J Clin Microbiol. 2015 Feb;53(2):398-409. doi: 10.1128/JCM.02473-14. Epub 2014 Nov 19.

12.

Drug susceptibility testing by dilution methods.

Jeannot K, Plésiat P.

Methods Mol Biol. 2014;1149:49-58. doi: 10.1007/978-1-4939-0473-0_6.

PMID:
24818896
13.

Antibiotic resistance determinants in a Pseudomonas putida strain isolated from a hospital.

Molina L, Udaondo Z, Duque E, Fernández M, Molina-Santiago C, Roca A, Porcel M, de la Torre J, Segura A, Plesiat P, Jeannot K, Ramos JL.

PLoS One. 2014 Jan 17;9(1):e81604. doi: 10.1371/journal.pone.0081604. eCollection 2014.

14.

Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Epub 2013 Oct 21. Erratum in: Antimicrob Agents Chemother. 2014 Mar;58(3):1833.

15.

A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa.

Fournier D, Garnier P, Jeannot K, Mille A, Gomez AS, Plésiat P.

J Clin Microbiol. 2013 Nov;51(11):3846-8. doi: 10.1128/JCM.01299-13. Epub 2013 Aug 21.

16.

Outbreak of metallo-β-lactamase VIM-2-positive strains of Pseudomonas aeruginosa in the Ivory Coast.

Jeannot K, Guessennd N, Fournier D, Müller E, Gbonon V, Plésiat P.

J Antimicrob Chemother. 2013 Dec;68(12):2952-4. doi: 10.1093/jac/dkt296. Epub 2013 Jul 25. No abstract available.

17.

Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; GERPA Study Group.

J Antimicrob Chemother. 2013 Aug;68(8):1763-71. doi: 10.1093/jac/dkt115. Epub 2013 Apr 29.

18.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Aug;68(8):1772-80. doi: 10.1093/jac/dkt098. Epub 2013 Apr 14.

19.

Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.

Milan O, Debroize L, Bertrand X, Plesiat P, Valentin AS, Quentin R, Van der Mee-Marquet N.

Antimicrob Resist Infect Control. 2013 Apr 4;2(1):12. doi: 10.1186/2047-2994-2-12.

20.

Alternatives to carbapenems in ESBL-producing Escherichia coli infections.

Fournier D, Chirouze C, Leroy J, Cholley P, Talon D, Plésiat P, Bertrand X.

Med Mal Infect. 2013 Feb;43(2):62-6. doi: 10.1016/j.medmal.2013.01.006. Epub 2013 Feb 19.

PMID:
23433608
Items per page

Supplemental Content

Loading ...
Write to the Help Desk